ANIK
Anika
Anika (Devanagari: अनिका) is a female given name of Sanskrit, Swedish, Dutch, Hebrew, and Māori origin and is also an alternate spelling of the name Aneeka, Annika Anikha
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 481.35M; Volume: 15.02K; AvgVol 3m: 114.88K; Beta: –;
Cost estimate:
P/E: 44.06; EPS: 0.78; EPS growth quarter/prev quarter: -181.10%;
EPS growth this year: 48.40%; EPS growth past 5 years: -5.50%;
EPS ttm: 0.78;
P/S: 4.17; P/B: 1.76; P/Cashflow: 3.63; P/FCF: 20.07;
Sales: 125.55M; Sales growth quarter/prev quarter: 1.00%; Sales growth past 5 years: 1.70%;
Profitability:
Gross Margin: 63.60%; Profit Margin: 9.00%; Operating Margin: 11.50%;
ROA – return on assets: 3.00%; ROE – return on equity: 3.90%; LT Debt/Equity: 0.17; Total Debt/Equity: 0.17;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.20%; Insider Transactions:-4.07%;
Institutional Ownership: 99.80%; Institutional Transactions: 5.03%;
Data update: 07/10/2020.